Evaluation of Dora Care for Supporting Fracture Liaison Services (FLS)

NCT07464171 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 217

Last updated 2026-03-11

No results posted yet for this study

Summary

What is the study about? This study is testing "Dora", an AI-powered assistant that can make phone calls to patients, for use in the Fracture Liaison Service (FLS). The FLS is a clinic that helps prevent more bone fractures after an initial "fragility fracture" (a break that happens easily, usually due to osteoporosis).

Why is this being done? FLS clinicians often have to spend a lot of time on routine phone calls for assessments and follow-ups. If Dora can safely and accurately collect patient information, it might save time for staff and still give patients a good experience.

What will happen to patients in the study? Invitation and consent - Patients with a new fragility fracture who are eligible will be invited to take part after informed consent.

Dora call - Patients will receive an automated phone call from Dora, at the start of their FLS pathway and at follow-up.

At intake, Dora will ask about risk factors for bone problems (e.g., smoking, alcohol use, family fracture history).

At follow-up, Dora will ask about medication use, side effects, falls, or new fractures.

Clinician call - Soon after, patients will have their usual phone appointment with an FLS clinician, who asks similar questions.

Surveys/interviews - Patients will be asked to complete a short questionnaire and take part in an optional interview to say how they felt about talking to Dora.

What about clinicians? Clinicians involved in the FLS pathway will be asked to complete a short survey and to take part in an optional interview to understand how useful Dora's reports might be in their work.

Who can take part? Patients - Age 50+, English-speaking, with a new fragility fracture, and able to use the phone.

Clinicians - Those working in FLS or similar bone health services. How long will it take? Each patient might be involved for up to about 7 months. The whole study will take about a year.

Conditions

  • AI (Artificial Intelligence)
  • Osteoporosis
  • Outpatient
  • Telemedicine
  • Automation
  • Risk Assesment
  • Bone Health

Interventions

DEVICE

Dora call

Patient participant will recieve a Dora call in addition to their standard clinical care telephone appointment

Sponsors & Collaborators

  • University College London Hospitals

    collaborator OTHER
  • University of York

    collaborator OTHER
  • Ufonia

    lead INDUSTRY

Principal Investigators

  • Aisling Higham, FRCOphth, MSc, MBBS · Ufonia

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-28
Primary Completion
2027-08-31
Completion
2027-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07464171 on ClinicalTrials.gov